Corning to Highlight Cancer Research Innovations Driven by 3D Cell Culture at AACR 2018
Corning Incorporated (NYSE: GLW) will showcase its latest solutions for cancer research, 3D cell culture, and drug discovery in exhibit 1842 at the 2018 American Association for Cancer Research Annual Meeting, April 14-18 in Chicago.
The world of 3D cell culture is expanding rapidly – from innovative organoid and spheroid development to 3D bioprinting applications and unique cancer research models for high-throughput screening. Corning is helping customers leverage 3D cell culture to create more in vivo-like studies that are accelerating cancer research and drug discovery.
To learn more about Corning Life Sciences products, contact a customer service representative at (800) 492-1110; outside the United States, call (978) 442-2200; or visit www.corning.com/lifesciences. To learn more about Corning’s 3D cell culture products, please visit: https://www.corning.com/worldwide/en/products/life-sciences/news-events/events/2018/04/corning-at-aacr-2018.html.